Recent Finacing
Recent Raise
iOnctura is a clinical-stage biopharmaceutical company developing selective oral small-molecule cancer therapies (PI3Kδ allosteric inhibitors and autotaxin inhibitors) targeting tumor proliferation, immune evasion, and fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
